Erica Sloan, PhD

Dr. Sloan is associate professor at Monash University in Australia. Dr. Sloan received her Ph.D. in cancer biology from the University of Melbourne. She completed her postdoctoral research in neuroimmunology at UCLA Medical Center and was an early-career fellow of the National Breast Cancer Foundation in Australia.

Dr. Sloan uncovered the role of sympathetic nervous system signals that drive the growth and metastasis of breast cancers, defining how signaling controls tumor cell invasion and remodeling of the tumor microenvironment. Her team recently demonstrated that sympathetic signaling may be targeted in breast cancer patients to modulate biomarkers of metastasis.

Erica Sloan, PhD headshot

Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.